Throughout the 2020s, pharmaceutical companies have been thrust under the spotlight like never before. Fortunately, they’ve largely responded exceptionally, delivering life-saving vaccine treatments at record…
With disruption to the traditional supply chain, managing quality and safety in today’s complex and ever-changing global Life Sciences market can be a challenge. In…
Over time Life Sciences regulatory processes will become increasingly data focused, driven by cross-functional data connectivity requirements and the growing need for structured data submission…
Ninety percent of the world’s data was generated in the past two years. In the next two years, the amount of information generated will continue…
Ways to leverage technology in medical affairs to achieve more as the role evolves Perhaps more so than any other part of a life science…
Livia Ng, Founder and CEO of Neuroute explains the significance of diversity in clinical research and why it is a non-negotiable for science, for medicine…
It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical…
Most life sciences Regulatory teams still think and work in terms of documents, paragraphs and sentences when putting together collateral for marketing authorisation and variations…
Released this July, the UK Government’s Women’s Health Strategy aimed to address a very complex problem – gender inequality across the healthcare sector. Whilst the…
Globally, researchers have long since been working on various aspects of medicine and clinical trials are a core part of developing medicinal and health development…
